Screener
Solid Biosciences Inc. SLDB Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337935
FAQ
- What is Solid Biosciences Inc.'s total equity?
- Solid Biosciences Inc. (SLDB) reported total equity of $374.08M in Q2 2026.
- How has Solid Biosciences Inc.'s total equity changed year-over-year?
- Solid Biosciences Inc.'s total equity increased by 44.8% year-over-year, from $258.29M to $374.08M.
- What is the long-term trend for Solid Biosciences Inc.'s total equity?
- Over 5 years (2020 to 2025), Solid Biosciences Inc.'s total equity has grown at a 6.4% compound annual growth rate (CAGR), from $132.09M to $180.01M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Solid Biosciences Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude